ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Hamburger Menu
Catalog
Cardiovascular Protection in PAD and Post-PCI: Pla ...
Cardiovascular Protection in PAD and Post-PCI: Planning Beyond the Revascularization
Faculty and Program
Eric Secemsky, MD, MSc, FSCAI
Atherothrombotic Risk Reduction in CAD, PAD, or Both
Sandeep Nathan, MD, MSc, FSCAI
Moderator
Case 1: Polyvascular Disease Patient: S/P Multivessel CAD PCI and New Diagnosis of PAD
Marc Bonaca, MD, MPH
PAD and PVI Pharmacotherapy
Dmitriy N. Feldman, MD, FSCAI
Case 2: PAD Patient Undergoing Lower Extremity PVI for CLTI
Learning Objectives
Upon completion of this activity, participants will be able to:
Discuss the residual risk for atherothrombotic events, stroke and vascular death in patients with CAD, PAD or both
Interpret the contemporary data on combined therapy with aspirin and DOAC in patients with polyvascular disease
Optimize the balance of bleeding risk and antithrombotic benefit in patients with PAD who underwent peripheral revascularization
Assess the interplay of patient-specific factors (e.g. type and timing of revascularization, comorbidities, concomitant medications) and antithrombotic therapy
Acknowledgement of Commercial Support
This activity is sponsored by SCAI and supported by
Janssen
.
Continuing Education Information
This activity is not certified for accredited continuing education.
Copyright
© 2022-2023 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Summary
Availability:
On-Demand
Expired on Jun 10, 2023
Cost:
FREE
Credit Offered:
1 Participation Credit
×
Cardiovascular Protection in PAD and Post-PCI: Planning Beyond the Revascularization Course List
Login
User Login
Continue with Google
OR
Login Name/Email
Password
Logging In…
Forgot Password
×